Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy.
Journal Information
Full Title: J Hepatocell Carcinoma
Abbreviation: J Hepatocell Carcinoma
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure All authors declare no conflicts of interest related to this manuscript."
Funding Disclosure
Evidence found in paper:
"The study was supported by the National Natural Science Foundation of Nanjing University of Chinese Medicine (No. XZR2023075); The Hospital Management Research of Jiangsu Province (No. JSYGY-3-2023-618); and Medical Science and Technology Development Foundation of Nanjing (No. YKK22095)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025